Eye Injections

Lucentis

Lucentis is the brand name of the anti-VEGF drug ranibizumab, which is injected into the eye to treat patients with certain eye conditions by slowing down vision loss.

Eylea

Eylea (Aflibercept) is a new FDA approved drug developed for the treatment of wet age-related macular degeneration (wet AMD). Age-related macular degeneration (AMD) is an eye condition that causes damage to the macula, a small area in the retina responsible for the sharp central vision that allows you to see fine details clearly. It is a leading cause of blindness and is most common in individuals above 50 years of age.

Avastin

Avastin is the brand name of the anti-VEGF drug bevacizumab, which is injected into the eye to treat patients with certain eye conditions by slowing down vision loss.

OZURDEX

OZURDEX is a tiny corticosteroid implant that is injected into the centre of the eyeball, which is known as the vitreous cavity, to help reduce swelling, improve vision, and alleviate eye pain in patients with certain inflammatory eye conditions.

Iluvien

ILUVIEN is a corticosteroid micro-implant that is injected into the centre of the eyeball, which is known as the vitreous cavity, to help reduce swelling, improve vision, and alleviate eye pain in patients with diabetic macular oedema who have been treated with corticosteroids in the past without having significant increased intraocular pressure.

Intravitreal Injection

An intravitreal injection is a non-invasive eye procedure where medication is injected into the vitreous cavity - the space at the back of your eyes, near the retina. The vitreous cavity is filled with vitreous humour gel, a jelly-like fluid.